Showing 13,841 - 13,860 results of 130,765 for search '(( i e decrease ) OR ( 5 ((((we decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 2.15s Refine Results
  1. 13841
  2. 13842

    Abl potentially regulates <i>CycE</i> expression via the Hippo pathway. by Henrike Becker (2576527)

    Published 2016
    “…(F) Triple mutation for <i>yki</i><sup><i>B5</i></sup> and <i>Abl</i><sup><i>4</i></sup>,<i>Dfd</i><sup><i>16</i></sup>, shows a decrease in the transformation rate from 100% in the double mutants for <i>Abl</i><sup><i>4</i></sup>,<i>Dfd</i><sup><i>16</i></sup> to 69% in the triple mutants. …”
  3. 13843
  4. 13844
  5. 13845

    Further optimisation and <i>in vitro</i> characterization of influenza A reporter viruses. by Monique I. Spronken (779529)

    Published 2015
    “…<p>(A) A schematic representation of adjustments to the 2UP_PA_eGFP_dPR construct. Silent mutations were introduced into the PA packaging region present in the PA CDS (mPR) and the dPR was decreased from 149 to 50 nucleotides (sPR). …”
  6. 13846

    Inflammation influences the membrane-localized β-catenin and E-cadherin interaction. by Bilge Debelec-Butuner (652580)

    Published 2014
    “…Memb: Membrane fraction, Nuc: Nuclear fraction, Cyto: Cytoplasmic fraction. <b>E.</b> Furthermore, total ubiquitination as well as β-catenin expression levels are increased in CM treated LNCaP cells whereas β-catenin ubiquitination is decreased. …”
  7. 13847
  8. 13848
  9. 13849
  10. 13850
  11. 13851
  12. 13852
  13. 13853
  14. 13854
  15. 13855

    MicroRNA-451a, microRNA-34a-5p, and microRNA-221-3p as predictors of response to antidepressant treatment by Wei-Hong Kuang (5255186)

    Published 2018
    “…Eight weeks after antidepressant treatment, the patients exhibited increased miRNA-451a levels, decreased miRNA-34a-5p and miRNA-221-3p levels, and reduced HAMD scores. …”
  16. 13856
  17. 13857
  18. 13858

    Rapamycin acts in the brain to decrease body weight gain. by Mark Hebert (558822)

    Published 2014
    “…<p>A and B: RAP i.c.v. injection (Day 0, broken line) induces a transient decrease in body weight gain (A), which results in prolonged shift in body weight (B). …”
  19. 13859
  20. 13860